Copy Link Print Information

GLX351322

55 Cited Publications
Revisión del cliente

Based on 55 publication(s) in Google Scholar

GLX351322 is an inhibitor of NADPH oxidase 4 (Nox4), and inhibits hydrogen peroxide production from NOX4-overexpressing cells with an IC50 of 5 μM.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.48%
  • No. CAS: 835598-94-2
  • Fòrmula: C21H25N3O5S
  • Peso molecular:431.51
  • Almacenamiento:
    Powder   -20°C, 3 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • GLX351322 Chemical Structure
    GLX351322 Chemical Structure
  • Experimental Validation Results for GLX351322
  • Experimental Validation Results for GLX351322
  • Experimental Validation Results for GLX351322
  • Experimental Validation Results for GLX351322
  • Experimental Validation Results for GLX351322
  • Experimental Validation Results for GLX351322
No. CAS: 835598-94-2
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of GLX351322:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) GLX351322

More
Customer Validation & Images
Bio/Physico-chemical AssayIFFlow CytometryCell Proliferation/Viability AssayCell Imaging/StainingWB
  • Bio/Physico-chemical Assay
  • IF
  • Flow Cytometry
  • Cell Proliferation/Viability Assay
  • Cell Imaging/Staining
  • WB

Ver todos los productos específicos de isoformas NADPH Oxidase

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • GLX351322 Chemical Structure
    GLX351322 Chemical Structure
    1/16
  • 1/16

    GLX351322 purchased from MedChemExpress. Usage Cited in: Cell Host Microbe. 2025 Apr 9;33(4):529-544.e9. [Abstract]

    Customer Validation
     GLX351322 (10 μM; 6 h) impaired IFN-I-mediated control of P. berghei infection in primary mouse (B6) hepatocyte cultures.

  • 1/16

    GLX351322 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Nov 21:e13299. [Abstract]

    Customer Validation
     Representative immunofluorescence images of ROS in C166 cells subjected to 0.4 mM H2O2 following NOX4 enzyme inhibition by GLX351322 (20 µM; 24 h) .

  • 1/16

    GLX351322 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Nov 21:e13299. [Abstract]

    Customer Validation
     Flow cytometry quantification of ROS in C166 cells subjected to 0.4 mM H2O2 following NOX4 enzyme inhibition by GLX351322 (20 µM; 24 h).

  • 1/16

    GLX351322 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Nov 21:e13299. [Abstract]

    Customer Validation
     Cell viability of C166 cells subjected to 0.4 mM H2O2 with or without GLX351322 (20 µM; 24 h) pretreatment.

  • 1/16

    GLX351322 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Nov 21:e13299. [Abstract]

    Customer Validation
     GLX351322 (20 µM). Assessment of intracellular ROS levels in C166 cells by fluorescence microscopy (DCFH-DA staining) following H2O2 challenge.

  • 1/16

    GLX351322 purchased from MedChemExpress. Usage Cited in: J Cell Mol Med. 2020 Feb;24(4):2552-2565. [Abstract]

    Customer Validation
     GLX351322 on the level of phospho-p38 MAPK in VCR-treated cells (*P < .05, NAC/VCR-treated cells compared to VCR-treated cells; GLX351322/VCR-treated cells compared to VCR-treated cells).

  • GLX351322